{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:20:30Z","timestamp":1787775630548,"version":"build-2784847793"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Infantile hemangioma (IH) is the most common benign vascular tumor of infancy. Propranolol is considered first-line therapy for IH. However, it is associated with side effects. Therefore, there was a need for alternative therapy. Atenolol, a selective b1-blocker may be free from such side effects. Hence, the present study aims to develop a more accurate estimate of the safety and efficacy of atenolol compared to propranolol in the treatment of IH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>A search of various literature databases (PubMed, Embase, Ovid, Scopus, Cochrane Central, CINAHL, Web of Science, and Google Scholar) was done to identify studies which compared propranolol versus atenolol in the treatment of IH. The combined odds ratio along with corresponding 95% confidence intervals (CIs) were evaluated using a fixed-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 300 articles were screened of which five studies including 116 patients in atenolol arm and 138 patients in the propranolol arm were analyzed. Atenolol was comparable to propranolol in terms of efficacy as no significant difference was seen between both the treatment arms in terms of hemangioma activity score (mean difference 0.25 [95% CI;[FIGURE DASH]0.21, 0.71]) and complete response (odds ratio [OR] =0.43; 95% CI; 0.17, 1.11;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.08,). Atenolol therapy was better than propranolol in terms of safety, i.e., serious\/potentially serious side effect, (OR = 0.11; 95% CI; 0.02, 0.51;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.005) and wheezing\/bronchial hyperreactivity (OR = 0.11; 95% CI; 0.02, 0.51;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.005).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The present meta-analysis provides evidence that atenolol has got a comparable efficacy and better safety profile with propranolol<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jiaps.jiaps_3_21","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T10:15:56Z","timestamp":1716545756000},"page":"279-286","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Oral Atenolol versus Propranolol in the Treatment of Infantile Hemangioma"],"prefix":"10.4103","volume":"27","author":[{"given":"Swapnil Annasaheb","family":"Pattanshetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya M","family":"Mahalmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phulen","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Mokkaram","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneer Abas","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin James","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Prajapat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Samujh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20240905","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJM199907153410307","article-title":"Hemangiomas in children","volume":"341","author":"Drolet","year":"1999","journal-title":"N Engl J Med"},{"key":"R3-2-20240905","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2014.01.905","article-title":"Atenolol versus propranolol for the treatment of infantile hemangiomas: A randomized controlled study","volume":"70","author":"\u00c1barz\u00faa-Araya","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R4-2-20240905","doi-asserted-by":"crossref","first-page":"e20160353","DOI":"10.1542\/peds.2016-0353","article-title":"Safety of oral propranolol for the treatment of infantile hemangioma: A systematic review","volume":"138","author":"L\u00e9aute-Labr\u00e8ze","year":"2016","journal-title":"Pediatrics"},{"key":"R5-2-20240905","first-page":"302","article-title":"Use of propranolol in treating hemangiomas","volume":"57","author":"Shayan","year":"2011","journal-title":"Can Fam Physician"},{"key":"R6-2-20240905","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"key":"R7-2-20240905","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ad.2011.05.003","article-title":"Propranolol in the treatment of infantile hemangioma: Clinical effectiveness, risks, and recommendations","volume":"102","author":"S\u00e1nchez-Carpintero","year":"2011","journal-title":"Actas Dermosifiliogr"},{"key":"R8-2-20240905","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jaad.2010.06.048","article-title":"Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants","volume":"65","author":"de Graaf","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R9-2-20240905","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaad.2010.11.056","article-title":"Atenolol: A promising alternative to propranolol for the treatment of hemangiomas","volume":"65","author":"Rapha\u00ebl","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R10-2-20240905","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.bjps.2013.07.035","article-title":"Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group","volume":"66","author":"de Graaf","year":"2013","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R11-2-20240905","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/pde.13177","article-title":"Atenolol versus propranolol for treatment of infantile hemangiomas during the proliferative phase: A retrospective noninferiority study","volume":"34","author":"Bayart","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"R12-2-20240905","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1378\/chest.13-1235","article-title":"Adverse respiratory effect of acute beta blocker exposure in asthama: A systematic review and meta-analysis of randomized controlled trails","volume":"145","author":"Morales","year":"2014","journal-title":"Chest"},{"key":"R13-2-20240905","first-page":"213","article-title":"Comparing the clinical, radiologic and biochemical effectiveness of atenolol and propranolol in the treatment of infantile hemangioma \u2013 A Randomized Controlled Trial","volume":"10","author":"Ashraf","year":"2019","journal-title":"Soc Sci Res Netw"},{"key":"R14-2-20240905","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1111\/jdv.15464","article-title":"Atenolol treatment for severe infantile hemangiomas: Comparison with a propranolol group of our centre","volume":"33","author":"Dakoutrou","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R15-2-20240905","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1111\/jdv.14590","article-title":"Atenolol treatment for severe Infantile Hemangiomas: A single-centre prospective study","volume":"32","author":"Alexopoulos","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R16-2-20240905","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/bjd.14687","article-title":"Ulcerated infantile haemangiomas: The effect of the selective beta-blocker atenolol on wound healing","volume":"175","author":"Ruitenberg","year":"2016","journal-title":"Br J Dermatol"},{"key":"R17-2-20240905","doi-asserted-by":"crossref","first-page":"e3908","DOI":"10.1097\/MD.0000000000003908","article-title":"Oral atenolol therapy for proliferating infantile hemangioma: A prospective study","volume":"95","author":"Ji","year":"2016","journal-title":"Medicine (Baltimore"},{"key":"R18-2-20240905","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/bjd.15317","article-title":"Atenolol treatment for infantile haemangioma","volume":"176","author":"Tasani","year":"2017","journal-title":"Br J Dermatol"},{"key":"R19-2-20240905","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2147\/NDT.S151802","article-title":"Risperidone for children and adolescents with autism spectrum disorder: A systematic review","volume":"14","author":"Maneeton","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R20-2-20240905","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1172\/JCI117241","article-title":"Cellular markers that distinguish the phases of hemangioma during infancy and childhood","volume":"93","author":"Takahashi","year":"1994","journal-title":"J Clin Invest"},{"key":"R21-2-20240905","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.jpedsurg.2013.08.020","article-title":"Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: A randomized controlled study","volume":"48","author":"Malik","year":"2013","journal-title":"J Pediatr Surg"},{"key":"R22-2-20240905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a006460","article-title":"Infantile hemangioma \u2013 Mechanism (s) of drug action on a vascular tumor","volume":"1","author":"Greenberger","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R23-2-20240905","first-page":"48","article-title":"Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"R24-2-20240905","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","article-title":"Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action","volume":"163","author":"Storch","year":"2010","journal-title":"Br J Dermatol"},{"key":"R25-2-20240905","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3892\/etm.2012.654","article-title":"Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis","volume":"4","author":"Stiles","year":"2012","journal-title":"Exp Ther Med"},{"key":"R26-2-20240905","first-page":"74","article-title":"Clinical pharmacokinetics of atenolol","volume":"53","author":"McAinsh","year":"1977","journal-title":"Postgr Med J"}],"container-title":["Journal of Indian Association of Pediatric Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jiaps.jiaps_3_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:36:47Z","timestamp":1787773007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jiaps.jiaps_3_21"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jiaps.jiaps_3_21","relation":{},"ISSN":["0971-9261"],"issn-type":[{"value":"0971-9261","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}